The Supervisory Board of Bayer AG has appointed Roche Pharmaceuticals CEO Bill Anderson (56) as new Chairman of the Management Board of Bayer AG with effect from 1 June 2023.
https://european-biotechnology.com/wp-content/uploads/2024/04/EB.com_Bill_Anderson_new_Bayer_CEO_kl..jpg940936Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-03-07 12:13:002024-07-16 17:15:50Bayer AG presents successor für CEO Baumann